The performance of companies tied to blockbuster drugs like Viagra presents a nuanced investment landscape . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the expiry in key regions has introduced considerable uncertainty . Investors are now facing the consequences of lower-cost alte⦠Read More